| Literature DB >> 34068969 |
Pedro Adão1, João Reboleira1, Marco Teles1, Beatriz Santos1, Nádia Ribeiro2, Carlos M Teixeira2, Mafalda Guedes3,4, João Costa Pessoa2, Susana Bernardino5.
Abstract
The chemical modification of porphyran hydrocolloid is attempted, with the objective of enhancing its antioxidant and antimicrobial activities. Sulfated galactan porphyran is obtained from commercial samples of the red algae Porphyra dioica using Soxhlet extraction with water at 100 °C and precipitation with isopropyl alcohol. The extracted porphyran is then treated with modified L-tyrosines in aqueous medium in the presence of NaOH, at ca. 70 °C. The modified tyrosines L1 and L2 are prepared through a Mannich reaction with either thymol or 2,4-di-tert-butylphenol, respectively. While the reaction with 2,4-di-tert-butylphenol yields the expected tyrosine derivative, a mixture of products is obtained with thymol. The resulting polysaccharides are structurally characterized and the respective antioxidant and antimicrobial activities are determined. Porphyran treated with the N-(2-hydroxy-3,5-di-tert-butyl-benzyl)-L-tyrosine derivative, POR-L2, presents a noticeable superior radical scavenging and antioxidant activity compared to native porphyran, POR. Furthermore, it exhibited some antimicrobial activity against S. aureus. The surface morphology of films prepared by casting with native and modified porphyrans is studied by SEM/EDS. Both POR and POR-L2 present potential applicability in the production of films and washable coatings for food packaging with improved protecting characteristics.Entities:
Keywords: antimicrobial activity; antioxidant activity; modified porphyran
Year: 2021 PMID: 34068969 PMCID: PMC8156949 DOI: 10.3390/molecules26102916
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Proposed structural formulas of the L-tyrosine derivatives L1 and L2.
Figure 2Structural formulas of the main repeating units of POR and the proposed structural formula of the modified porphyran POR-L2.
Figure 3Close-up of the FTIR spectra obtained for POR and POR-L2 in KBr pellet.
Selected IR bands (in cm−1) for POR and POR-L2.
| Compound | υ(O-H) | υ(C-H) | υ(S=O) | υ(C-O, ether) | υ(C-O-SO3) |
|---|---|---|---|---|---|
|
| 3444.7 ( | 2929.3 ( | 1259.8 ( | 931.9 ( | 815.5 ( |
|
| 3418.2 ( | 2932.2 ( | 1252.1 ( | 931.4 ( | 817.2 ( |
b: broad, sh: shoulder, w: weak, m: medium, s: strong; vs: very strong.
Figure 4UV–vis absorption spectra of POR and POR-L2 in water, at a concentration of 0.2 mg/mL. The spectra were measured with a 1 cm optical path quartz cell.
Figure 51H NMR spectrum of POR-L2 with suppression of the D2O residual signal.
Figure 6Long-range 1H-1H COSY spectrum of POR-L2, at 50 °C.
Obtained absorbances for the tested porphyrans after 30 min in the ferric reduction activity screening
| Sample a | t (min) | Abs 510 nm b |
|---|---|---|
| Control c | 0 | 0.042 ± 0.003 |
| 30 | 0.045 ± 0.002 | |
| 30 | 0.108 ± 0.002 | |
|
| 30 | 0.161 ± 0.002 |
a Concentration of PORs in the samples was 0.2 mg/mL and [FeIII(Phen)3]Cl3 was 0.55 mM. Experiments were performed in triplicate using a quartz cell with a 1 cm optical path. b The obtained values are presented as mean ± SD. c The control sample was [FeIII(Phen)3]Cl3 in water at 0.55 mM (1.65 × 10−6 mol, 3 mL), in the absence of porphyrans. d The presented absorbances were obtained for after subtraction with the measured absorbances at 510 nm for POR and POR-L2 at 0.2 mg/mL, in water, as described in Section 2.3 (Table S1).
Observed absorbance changes obtained for the tested porphyrans
| Sample a | Δ Abs 524 nm b |
|---|---|
| Control | 0.0886 ± 0.0043 |
|
| 0.0663 ± 0.0018 |
|
| 0.0464 ± 0.0031 |
a Concentration of the porphyran samples was 0.2 mg/mL. b Experiments were performed in triplicate and the results are presented as mean ± SD.
Observed absorbance changes obtained for the tested porphyrans
| Sample a | Δ Abs 500 nm b |
|---|---|
| Control c | 0.0351 ± 0.0034 |
|
| 0.0065 ± 0.0031 |
|
| 0.0012 ± 0.0010 |
a Concentration of the porphyran samples was 0.16 mg/mL. b Experiments were performed in triplicate and the results are presented as mean ± SD. c The control was carried out with distilled water instead of the porphyran sample.
Figure 7Electron microscope images of the produced films. Low magnification images: (a) POR; (b) POR/gly; (c) POR-L2; (d) POR-L2/gly. High magnification images: (e) POR (arrows highlight pores); (f) POR/gly; (g) POR-L2 (arrows highlight pores, a crack is indicated with dashed arrow); (h) POR-L2/gly.
Average elemental composition of produced films determined by EDS area analysis.
| POR | POR/gly | POR-L2 | POR-L2/gly | |
|---|---|---|---|---|
| C (at%) | 59.2 ± 1.1 | 45.8 ± 1.2 | 57.8 ± 2.1 | 46.9 ± 5.8 |
| O (at%) | 38.4 ± 1.6 | 46.5 ± 3.3 | 37.8 ± 2.8 | 39.4 ± 4.9 |
| S (at%) | 1.4 ± 0.3 | 3.3 ± 0.2 | 1.0 ± 0.1 | 4.3 ± 0.7 |
| Mg (at%) | 0.2 ± 0.1 | 0.5 ± 0.1 | 0.1 ± 0.0 | 0.1 ± 0.0 |
| Na (at%) | 0.4 ± 0.1 | 0.7 ± 0.2 | 0.4 ± 0.1 | 1.4 ± 0.1 |
| K (at%) |
| 0.9 ± 0.3 | 2.9 ± 0.7 | 7.6 ± 2.2 |
| Ca (at%) |
| 0.6 ± 0.2 |
| 0.3 ± 0.1 |
nd: not detected.
Percentual reduction of microbial growth for strains of S. aureus and E.coli under exposure to porphyran and modified porphyran film solutions. Results presented are the mean ± std. deviation of three independent assays, in which four technical replicas were conducted. nd = not detectable.
| Solution Concentration (mg/mL) | % Growth Inhibition | |
|---|---|---|
|
|
| |
|
| ||
| 0.2 |
|
|
| 0.4 |
|
|
| 0.8 | 4.9 ± 0.7 |
|
| 1.6 | 6.6 ± 0.4 |
|
|
| ||
| 0.2 |
|
|
| 0.4 |
|
|
| 0.8 | 27.3 ± 5.8 | 3.1 ±2.5 |
| 1.6 | 56.3 ± 3.0 | 4.5 ± 2.62 |
|
| ||
| 0.2 |
| |
| 0.4 | 18.9 ± 2.1 |
|
| 0.8 | 43.3 ± 4.7 |
|
| 1.6 | 65.7 ± 2.1 |
|